MedTrace Logo

Effect of Vitamin D Supplementation on Blood Pressure and HbA1c Levels in Patients With T2D

NCT01585051 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 51

Last updated 2012-04-25

No results posted yet for this study

Summary

The effect of administration of vitamin D is tested on the long-term control of blood sugar (as measured by HbA1-c levels in blood) and mean blood pressure (as measured by 24 hour blood pressure profiles)in patients with stable type 2 diabetes mellitus

Conditions

  • Diabetes Mellitus Type 2

Interventions

DRUG

25(OH) vitamin D

300 000 U intramuscularly, one dosage, in subjects with 25 (OH) vit D levels below 80 nmol/L, another dosage of 150 000 U after 3 months if 25(OH)vit D levels continue to be below 80 nmol/L.

DRUG

0.9 % NaCl

1 ml of 0.9 % of NaCl at the beginning and 0.5 ml of 0.9 % NaCl after three months

Sponsors & Collaborators

  • Kantonsspital Baselland Bruderholz

    lead OTHER

Principal Investigators

  • Reto Krapf, MD · Department of Medicine, Kantonsspital Bruderholz, University of Basel, Switzerland

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2010-06-30
Completion
2010-06-30

Countries

  • Switzerland

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01585051 on ClinicalTrials.gov